SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Magnite, Inc. provides a technology solution to automate the purchase and sale of digital advertising inventory for buyers and sellers. It features applications and services for digital advertising sellers including websites, mobile applications, and other digital media properties. The company was founded by Frank Addante, Duc Chau, Craig Roah, Julie Mattern and Brian D. Baumgart on April 20, 2007 and is headquartered in New York, NY.

Magnite Inc

Magnites strong quarterly results and raised full-year outlook are driving attention, with traders highlighting continued connected-TV growth and improved execution. The reaction is broadly bullish, though some remain focused on market volatility and the slower, uncertain revenue impact of Googles ad-tech remedies.

TRON (TRX) is a cryptocurrency launched in 2018. TRON has a current supply of 95,022,365,191.094644 with 95,022,375,662.737444 in circulation. The last known price of TRON is 0.30232528 USD and is down -8.04 over the last 24 hours. It is currently trading on 1389 active market(s) with $1,465,217,312.79 traded over the last 24 hours. More information can be found at https://trondao.org/.

Tron

TRON is drawing attention amid a pullback and choppy price action, with traders debating whether the weakness is a healthy consolidation or a sign of further downside. Bullish holders point to its perceived resilience and role in stablecoin transfers, while others complain that the coin has lagged or moved sideways.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

ARM is drawing attention amid a sharp pullback alongside other semiconductor and AI stocks, with traders citing broad sector weakness, rising yields and concerns that its valuation leaves little room for disappointment. The debate pits dip-buyers pointing to AI-related CPU and data-center demand against bears warning of continued repricing and weak momentum.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas preliminary outlook for declining DefenCath reimbursement through 2027 has fueled concerns about CorMedixs revenue and adoption prospects. Bullish traders counter that DaVitas modeling is uncertain and not definitive guidance for CMS payments or CorMedix sales, pointing to the finalized reimbursement framework as a source of support.

Charter Communications, Inc. engages in providing broadband communications services. Its services include Spectrum TV, Spectrum Internet, and Spectrum Voice. It offers business-to-business Internet access, data networking, business telephone, video and music entertainment services, and wireless backhaul. Its advertising sales division, Spectrum Reach, offers local, regional, and national businesses the opportunity to advertise in individual and multiple service areas on cable television networks and advanced advertising platforms. The company was founded in 1993 and is headquartered in Stamford, CT.

Charter Communications Inc. - Ordinary Shares - Class A

Persistent broadband customer losses, competitive pressure, and Charters heavy debt dominate discussion, with Q2 results underscoring the divide: bears see a deteriorating cable business and paused buybacks, while bulls point to mobile growth, cash flow, and potential Cox merger synergies as support for a turnaround.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons strong third-quarter results, driven by growth in Dupixent and Eylea HD, have sparked a sharp share-price breakout and renewed talk of new highs. Traders are weighing that momentum against continued declines in legacy Eylea sales and whether newer products can sustain growth.

Sony Group Corp. engages in the development, design, manufacture, and sale of electronic equipment, instruments, devices, game consoles, and software for consumers, professionals and industrial markets. It operates through the following segments: Game and Network Services, Music, Pictures, Entertainment Technology & Services, Imaging and Sensing Solutions, Financial Services, and Others. The Game and Network Services segment deals with gaming machines, software and network services. The Music segment produces and publishes music and provides image media platforms. The Pictures segment handles film production, television program creation, and media networks. The Home Entertainment and Sound segment offers LCD televisions, home audio, Blu-ray Disc players and recorders, and memory-based portable audio devices. The Imaging and Sensing Solutions segment includes the image sensors business. The Financial Services segment manages the life insurance and non-life insurance operations and banking business. The Others segment consists of various operating activities, including the disc manufacturing and recording media businesses. The company was founded by Akio Morita and Masaru Ibuka on May 7, 1946 and is headquartered in Tokyo, Japan.

Sony Group Corporation - ADR

Sony Group Corporation

Sonys plan to end physical disc releases for new PlayStation games in 2028 is driving debate: many traders warn of consumer backlash, boycotts and weaker console demand, while others argue a digital shift could reduce costs and improve margins.

Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is being discussed amid a broad-market pullback, with many traders warning that heavy AI spending and lofty tech valuations, alongside rising oil, inflation and bond-yield concerns, could pressure stocks further. Others view the weakness as a buying opportunity and favor holding or adding to the diversified ETF for the long term.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

Aetnas weaker 2027 Medicare Advantage star ratings are drawing attention, with traders concerned that fewer plans may qualify for quality bonuses and pressure CVSs insurance business. The discussion contrasts CVSs setback with Humanas improved ratings, while some traders argue the impact may already be priced in and remain bullish on CVSs turnaround.

BNB (BNB) is a cryptocurrency . BNB has a current supply of 131,511,348.93. The last known price of BNB is 702.2705794 USD and is down -0.19 over the last 24 hours. It is currently trading on 3523 active market(s) with $1,103,086,320.06 traded over the last 24 hours. More information can be found at https://bnbchain.org/en.

Binance

Binances reported record-scale security breach and temporary withdrawal suspension dominate discussion, with traders worried about customer-fund safety, exchange solvency, and spillover across crypto markets. Some cite Binances stated recovery and coverage plans as reassurance, while others question the explanation and speculate about an insider attack; those suspicions remain unverified.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$RDCM Q2 &#39;26 Earnings Results &amp; Recap

RADCOM reaffirms its full-year 2026 revenue outlook of $57 to $63 million, with a midpoint of $60 million, and expects to remain profitable on a non-GAAP basis in 2026.

Stocktwits

Radcom

 Q2 '26 Earnings Results & Recap

RADCOM reaffirms its full-year 2026 revenue outlook of $57 to $63 million, with a midpoint of $60 million, and expects to remain profitable on a non-GAAP basis in 2026.

This account has been verified as an official STOCKTWITS representative.